RankAlphaRankAlpha
Today
Discover
Research
Research TapeOpportunitiesEarnings WatchMemosMacroNews Archive
Portfolios
Methodology
Tools
Screener
Compare
Watchlist
Calendar
Alerts
Settings
Help
RankAlpha logoRankAlpha logo
  • Today
  • Discover
  • Portfolios
  • Methodology
WatchlistCompare (0)
© 2026 RankAlpha
DocsTrustDisclaimerPrivacyTermsUnsubscribeAbout
    RankAlphaRankAlpha
    Today
    Discover
    Research
    Research TapeOpportunitiesEarnings WatchMemosMacroNews Archive
    Portfolios
    Methodology
    Tools
    Screener
    Compare
    Watchlist
    Calendar
    Alerts
    Settings
    Help
    ResearchLive tape
    1,887 events tracked3,255 memos tracked56 notes tracked
    Research TapeFreshness shown inline

    Research Tape

    Open ScreenerOpen RankingsOpen Compare
    Visible tape
    178
    Desk focus
    Research Tape
    Latest visible update
    2026-07-18 08:35 ET
    Filters
    Desk
    Research Tape
    Events
    Memos
    Macro
    Freshness
    Event impact floor
    Memo confidence
    Event tape/Research Tape

    178 items

    Open ScreenerOpen RankingsFull Event ArchiveFull Memo Desk
    Event tape lead
    2026-07-18 08:35 ET
    Uber seals $15 billion Delivery Hero takeover

    2026-07-18 08:35 ET

    Open lead event
    Memo signal
    2026-07-18
    Magnera

    Primary-source evidence supports a cautious monitoring-positive view: Q2 execution was broadly stable, guidance was maintained, cash flow was strong, and debt was reduced. The Caerphilly divestiture adds a self-help angle. However, social, options, short-inte...

    Open memo
    Macro
    Macro desk / 30d
    Pulse

    Debt, leverage & balance-sheet health update: June 30, 2026

    Open macro note
    EventUBERImpact 85
    Uber seals $15 billion Delivery Hero takeover

    Uber seals $15 billion Delivery Hero takeover

    Freshness
    2026-07-18 08:35 ET
    Source trail
    External coverage
    tucsonpost.com
    Open source article
    EventATAIImpact 85m&a
    Lilly enters psychedelic realm through $2.8bn AtaiBeckley takeover

    Lilly enters psychedelic realm through $2.8bn AtaiBeckley takeover

    Freshness
    2026-07-18 00:05 ET
    Source trail
    External coverage
    finance.yahoo.com
    Open source article
    EventATAIImpact 85m&a
    AtaiBeckley Soars as Eli Lilly Agrees to $2.8 Billion Buyout

    AtaiBeckley Soars as Eli Lilly Agrees to $2.8 Billion Buyout

    Freshness
    2026-07-18 00:05 ET
    Source trail
    External coverage
    finance.yahoo.com
    Open source article
    MemoMAGNmediumExperimental

    Magnera

    Primary-source evidence supports a cautious monitoring-positive view: Q2 execution was broadly stable, guidance was maintained, cash flow was strong, and debt was reduced. The Caerphilly divestiture adds a self-help angle. However, social, options, short-inte...

    Memo freshness
    2026-07-18
    Coverage
    Coverage available
    Base target $15.30Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoSTUBmediumExperimental

    StubHub

    News flow is mixed: Q1 results, reaffirmed guidance, and product-initiative coverage were constructive, while the July investigation headline is a clear negative overhang. Social, options, short-interest, employee-rating, and detailed analyst-revision data ar...

    Memo freshness
    2026-07-18
    Coverage
    Coverage available
    Base target $10.25Base-case probability 55%Closest price scenario: Base case
    Open memoOpen ticker
    MemoBEATneutralmediumExperimental

    HeartBeam

    Issuer-driven news flow has been active and mostly constructive around the June strategic shift and ahead-of-schedule ALIGN-ACS enrollment. However, social coverage is unavailable, analyst revisions are not reliable, and post-news price attribution is unavail...

    Memo freshness
    2026-07-18
    Coverage
    Coverage available
    Base target $0.65Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    EventImpact 85
    Judge delays ruling on California's bid to freeze Paramount's $111B takeover of Warner Bros. Discovery

    Judge delays ruling on California's bid to freeze Paramount's $111B takeover of Warner Bros. Discovery

    Freshness
    2026-07-17 16:16 ET
    Source trail
    External coverage
    foxbusiness.com
    Open source article
    EventCOPImpact 84
    ConocoPhillips buys into BP’s contract to redevelop Iraq’s supergiant Kirkuk oilfield

    ConocoPhillips buys into BP’s contract to redevelop Iraq’s supergiant Kirkuk oilfield

    Freshness
    2026-07-17 08:57 ET
    Source trail
    Systemic monitor
    www.ft.com
    Open source article
    EventImpact 83
    Airbus Wins Major Order from Air China to Cement Regional Hold

    Airbus Wins Major Order from Air China to Cement Regional Hold

    Freshness
    2026-07-17 05:36 ET
    Source trail
    External coverage
    www.bloomberg.com
    Open source article
    EventRFImpact 90earnings
    Regions Financial Corp. Announces Quarterly Earnings Release Dates for 2027

    Regions Financial Corp. Announces Quarterly Earnings Release Dates for 2027

    Freshness
    2026-07-17 00:01 ET
    Source trail
    External coverage
    www.businesswire.com
    Open source article
    MemoGEhighExperimental

    GE Aerospace

    Primary-source earnings evidence is strongly constructive, with Q2 growth, higher cash flow, and guidance raised across the board. Supplied headlines indicate high attention but a muted or negative near-term tape despite the strong report; the exact move and...

    Memo freshness
    2026-07-17
    Coverage
    Coverage available
    Base target $389.24Base-case probability 55%Closest price scenario: Base case
    Open memoOpen ticker
    MemoESImediumExperimental

    Element Solutions

    Headline sentiment has shifted positively because of the announced Solstice transaction, but the thesis is now merger-arbitrage rather than a straightforward operating-growth call. The scheduled July 16 post-earnings trigger was not a reported print; company...

    Memo freshness
    2026-07-17
    Coverage
    Coverage available
    Base target $39.00Base-case probability 55%Closest price scenario: Base case
    Open memoOpen ticker
    MemoUNHhighExperimental

    UnitedHealth Group

    News tone is strongly positive after the Q2 release and guidance increase, with packet coverage reporting a roughly 10% post-print rally. The primary earnings evidence is strong, but social coverage and post-print analyst revisions are unavailable; therefore,...

    Memo freshness
    2026-07-17
    Coverage
    Coverage available
    Base target $460.00Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoAALmediumExperimental

    American Airlines Group

    Tone is constructive but monitoring-oriented. The packet has strong primary operating context from Q1, while the latest AAL-specific earnings print, analyst revisions, and price reaction are unavailable. The official company source confirms the Q2 call is sch...

    Memo freshness
    2026-07-17
    Coverage
    Coverage available
    Base target $18.50Base-case probability 55%Closest price scenario: Bear case
    Open memoOpen ticker
    MemoWTSneutralmediumExperimental

    Watts Water

    Primary operating evidence is constructive, but forward visibility is concentrated in the scheduled August earnings event. Direct water-management comparators improve peer context, but analyst revision data and social metrics remain unavailable. The setup rem...

    Memo freshness
    2026-07-17
    Coverage
    Coverage partial
    Base target $356.00Base-case probability 55%Closest price scenario: Base case
    Open memoOpen ticker
    MemoMANEmediumExperimental

    Veradermics

    News tone is moderately positive, led by the July 15 clinical update and prior positive Study 302 framing. Social coverage, options data, short interest, employee sentiment, and verified analyst revision data were not supplied; missing market-reaction and rev...

    Memo freshness
    2026-07-17
    Coverage
    Coverage available
    Base target $105.00Base-case probability 1%Closest price scenario: Base case
    Open memoOpen ticker
    MemoVATEmediumExperimental

    INNOVATE

    Primary-source evidence supports a modestly positive but monitoring-style view, led by Q1 Infrastructure strength and the DBM dividend announcement. Coverage is low, analyst reaction and targets are unavailable, and social context is absent; those gaps preven...

    Memo freshness
    2026-07-17
    Coverage
    Coverage available
    Base target $10.20Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoABTmediumExperimental

    Abbott Laboratories

    News tone is strongly positive following the Q2 beat and raised EPS guidance. Trusted coverage reported an initial premarket gain, but the precise full-session reaction and post-print analyst revisions are not consistently available. Social coverage is absent...

    Memo freshness
    2026-07-17
    Coverage
    Coverage partial
    Base target $114.00Base-case probability 52%Closest price scenario: Base case
    Open memoOpen ticker
    MemoANGOmediumExperimental

    AngioDynamics

    Post-earnings tone is constructive: company results showed strong Med Tech growth and FY2027 guidance, while Canaccord raised its target; Investing.com displayed ANGO up 11.31% in its July 14 update ([source](https://www.investing.com/news/analyst-ratings/can...

    Memo freshness
    2026-07-17
    Coverage
    Coverage available
    Base target $18.50Base-case probability 55%Closest price scenario: Bear case
    Open memoOpen ticker
    MemoABMmediumExperimental

    ABM Industries

    Primary-source tone is constructive after Q2, with record revenue, organic growth, bookings, cash flow, and reaffirmed outlook. Stored secondary context reports Baird raised its target to $48 from $45 while retaining Neutral, but analyst breadth and immediate...

    Memo freshness
    2026-07-17
    Coverage
    Coverage available
    Base target $52.43Base-case probability 55%Closest price scenario: Base case
    Open memoOpen ticker
    MemoFGIneutralmediumExperimental

    FGI Industries

    Primary operating evidence is available, but coverage and market-sentiment data are thin. The Q1 report mixed improving product categories and cost discipline with declining revenue, losses, tariff uncertainty, and liquidity sensitivity. This supports monitor...

    Memo freshness
    2026-07-17
    Coverage
    Coverage available
    Base target $5.25Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoGShighExperimental

    Goldman Sachs Group

    Reuters coverage reported an immediate post-print GS share increase of about 7.2% after the earnings release, while the packet records a July 16 headline about GS losses, indicating subsequent digestion. Post-print analyst reaction is constructive but mixed,...

    Memo freshness
    2026-07-17
    Coverage
    Coverage partial
    Base target $1142.24Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoPLDneutralhighExperimental

    Prologis

    The earnings-news tone is positive: trusted coverage reported a 4.04% premarket rise after the Q2 release, but a verified full-session reaction and post-print analyst revisions are unavailable. Social coverage was not provided, so it is not used as a thesis d...

    Memo freshness
    2026-07-17
    Coverage
    Coverage available
    Base target $154.25Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoHRIneutralmediumExperimental

    Herc

    Primary operating evidence is strong for Q1 but earnings-specific evidence for the scheduled Q2 follow-up remains unavailable. A secondary StockStory recap described Q1 revenue and EPS as beats while characterizing full-year guidance as comparatively weak [#P...

    Memo freshness
    2026-07-17
    Coverage
    Coverage partial
    Base target $176.27Base-case probability 50%Closest price scenario: Bear case
    Open memoOpen ticker
    MemoWFChighExperimental

    Wells Fargo

    The July 14 company Form 8-K and earnings release confirm a strong Q2 beat and broad operating improvement [#SEC-8K-2026-07-14]. Later post-print coverage remained mixed: Reuters reported shares fell as much as 4.4% as unchanged guidance and slight NIM compre...

    Memo freshness
    2026-07-17
    Coverage
    Coverage available
    Base target $99.00Base-case probability 50%Closest price scenario: Bear case
    Open memoOpen ticker
    MemoWGSmediumExperimental

    GeneDx

    News tone is mixed-to-negative after the Q1 guidance reset, despite strong testing-volume growth. Social, options, short-interest, employee-review, and post-print analyst-revision data were unavailable in the packet; missing coverage is not treated as positiv...

    Memo freshness
    2026-07-17
    Coverage
    Coverage available
    Base target $72.00Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoNFLXneutralmediumExperimental

    Netflix

    News tone is negative around the July 16 earnings release, with multiple July 17 headlines describing a sharp NFLX selloff. Primary company evidence is operationally solid and guidance remains intact, but the negative reaction, lower Q3 growth outlook, and un...

    Memo freshness
    2026-07-17
    Coverage
    Coverage partial
    Base target $82.00Base-case probability 50%Closest price scenario: Bear case
    Open memoOpen ticker
    MemoCNSmediumExperimental

    Cohen Steers

    The company release is operationally positive, but the evidence packet contains no recent-news stream or analyst-revision data. Initial market reaction appears constructive, while attribution and durability remain unconfirmed pending the earnings call. Social...

    Memo freshness
    2026-07-17
    Coverage
    Coverage available
    Base target $78.00Base-case probability 45%Closest price scenario: Base case
    Open memoOpen ticker
    MemoTCXneutralmediumExperimental

    Tucows

    News flow is limited and mixed: stored earnings context is cautiously constructive on Wavelo, Domains, and debt reduction but highlights liquidity constraints and Ting uncertainty. No social coverage, options data, short-interest data, employee score, or anal...

    Memo freshness
    2026-07-17
    Coverage
    Coverage available
    Base target $9.40Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoAARDmediumExperimental

    Aardvark Therapeutics

    News tone is negative because the lead programs remain paused and the cardiac-safety review is unresolved. Social, options, short-interest, employee-review, and post-print price-reaction data are unavailable in the packet; missing analyst reaction is not trea...

    Memo freshness
    2026-07-17
    Coverage
    Coverage available
    Base target $5.75Base-case probability 45%Closest price scenario: Base case
    Open memoOpen ticker
    MemoGEFmediumExperimental

    Greif

    Primary-source evidence is strong, but recent news and social coverage are sparse and analyst revision data is unavailable. The setup is constructive but primarily a monitoring thesis ahead of the dated Q3 earnings event; no missing sentiment inputs are treat...

    Memo freshness
    2026-07-17
    Coverage
    Coverage available
    Base target $78.00Base-case probability 55%Closest price scenario: Base case
    Open memoOpen ticker
    MemoKMTSneutralmediumExperimental

    Kestra Medical

    The earnings release tone is constructive, but the evidence is concentrated in company/SEC reporting. The July 16 anchor price was $23.98; analyst revision data, options positioning, short interest, employee sentiment, and a verified post-print reaction are u...

    Memo freshness
    2026-07-17
    Coverage
    Coverage available
    Base target $27.00Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoCHMGmediumExperimental

    Chemung Financial

    News coverage is sparse and limited mainly to earnings snapshots and corporate filings. The July 16 price move was positive, but no checked source attributed it to Q2 results, which remain unconfirmed. Social, options, short-interest, employee, and post-print...

    Memo freshness
    2026-07-17
    Coverage
    Coverage available
    Base target $73.00Base-case probability 45%Closest price scenario: Base case
    Open memoOpen ticker
    MemoCASSneutralmediumExperimental

    Cass Information

    Cautious-neutral. The latest confirmed company filing supports improving profitability and margin, but the scheduled T+1 run lacks confirmed Q2 operating results, analyst reaction, estimate changes beyond the Zacks preview, and a result-linked price reaction....

    Memo freshness
    2026-07-17
    Coverage
    Coverage available
    Base target $54.00Base-case probability 55%Closest price scenario: Base case
    Open memoOpen ticker
    MemoPFISmediumExperimental

    Peoples Financial Services

    Sentiment is thin and cautiously neutral: coverage is low, social context is absent, and no post-print analyst revision data was available. The official IR page checked on 2026-07-17 lists the April 30 Q1 release as the latest confirmed earnings item, so the...

    Memo freshness
    2026-07-17
    Coverage
    Coverage available
    Base target $68.00Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoCFGneutralmediumExperimental

    Citizens Financial Group

    News tone is positive and headline buzz is high after the Q2 beat, but the immediate market reaction was mixed or limited. Social coverage, options skew, short interest, and employee-rating data were unavailable; the zero values are placeholders for unavailab...

    Memo freshness
    2026-07-17
    Coverage
    Coverage partial
    Base target $78.20Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoISRGmediumExperimental

    Intuitive Surgical

    News tone is negative immediately after Q2 despite strong reported operating results. Social, options, short-interest, employee, analyst-revision, and target-change data are unavailable; missing analyst reaction is not positive evidence and caps confidence.

    Memo freshness
    2026-07-17
    Coverage
    Coverage partial
    Base target $423.00Base-case probability 50%Closest price scenario: Bear case
    Open memoOpen ticker
    MemoBLNEneutralmediumExperimental

    Beeline

    Recent headlines are constructive around MagicBlocks, AI positioning, index inclusion, and the scheduled Q2 update, but coverage is primarily company-driven or secondary. No verified analyst-revision set or post-earnings market-reaction evidence is available....

    Memo freshness
    2026-07-17
    Coverage
    Coverage available
    Base target $1.05Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoCneutralhighExperimental

    Citigroup

    The T+3 earnings follow-up is mixed rather than decisively bullish: Citi delivered a broad operating beat, but the stock fell 5.3% on July 14 as expense concerns overshadowed results [#SEC-8K-2026-07-14] [Kiplinger](https://www.kiplinger.com/investing/stocks/...

    Memo freshness
    2026-07-17
    Coverage
    Coverage partial
    Base target $155.45Base-case probability 50%Closest price scenario: Bear case
    Open memoOpen ticker
    MemoRGNXneutralmediumExperimental

    REGENXBIO

    Primary-source evidence is strong, but the thesis remains cautious and monitoring-oriented. Recent headlines indicate elevated attention, including a reported after-hours selloff, but the packet lacks a verified price-reaction series, options data, short-inte...

    Memo freshness
    2026-07-17
    Coverage
    Coverage available
    Base target $10.50Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoBACmediumExperimental

    Bank of America

    The primary 2Q26 SEC filing provides concrete operating evidence, but the T+3 follow-up still lacks verified analyst revisions and market-reaction attribution. Recent news coverage is positive but secondary, and social coverage is unavailable; this supports c...

    Memo freshness
    2026-07-17
    Coverage
    Coverage partial
    Base target $67.07Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoFNBneutralhighExperimental

    F.N.B

    The latest primary-source earnings release is constructive, and the July 17 earnings call is the next dated company-specific checkpoint. This remains an early T+1 follow-up with no verified analyst revision data or reliable post-release price reaction in the...

    Memo freshness
    2026-07-17
    Coverage
    Coverage partial
    Base target $21.00Base-case probability 55%Closest price scenario: Bear case
    Open memoOpen ticker
    MemoTRUGmediumExperimental

    TruGolf

    Primary-company earnings commentary is mixed: losses and operating cash use improved, but revenue and gross margin weakened. The packet contains no recent news, sufficient social context, or usable analyst-revision data, so sentiment remains low-signal and th...

    Memo freshness
    2026-07-17
    Coverage
    Coverage available
    Base target $1.25Base-case probability 55%Closest price scenario: Base case
    Open memoOpen ticker
    MemoFATNneutralmediumExperimental

    Fatpipe

    Operating tone is cautiously positive after the strong FY2026 Q4 report, but the investment setup remains neutral. The July 2 ATM filing adds a financing overhang, while the July 30 results webinar is the next dated information event. Recent-news, social, opt...

    Memo freshness
    2026-07-17
    Coverage
    Coverage available
    Base target $4.80Base-case probability 55%Closest price scenario: Base case
    Open memoOpen ticker
    MemoUSNAmediumExperimental

    USANA Health Sciences

    Low-coverage, low-buzz setup with no recent-news or sufficient social dataset in the packet. Stored secondary earnings context indicates mixed market-reaction evidence and no reliable analyst-revision dataset; confidence should remain moderate despite strong...

    Memo freshness
    2026-07-17
    Coverage
    Coverage available
    Base target $26.00Base-case probability 55%Closest price scenario: Base case
    Open memoOpen ticker
    MemoGALTmediumExperimental

    Galectin Therapeutics

    News tone is positive after the June 23 FDA update and reported roughly 22% share-price surge, but the catalyst appears substantially priced in. No social context or analyst revision data is available, and no reliable direct peer set is available. The determi...

    Memo freshness
    2026-07-17
    Coverage
    Coverage partial
    Base target $5.25Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoUSBneutralhighExperimental

    US Bancorp

    News tone is positive after the record-revenue Q2 release and strong EPS growth. Social, options, short-interest, employee, consensus-surprise, analyst-revision, and verified post-release price-reaction data are unavailable; therefore this remains a cautious...

    Memo freshness
    2026-07-17
    Coverage
    Coverage available
    Base target $69.00Base-case probability 55%Closest price scenario: Base case
    Open memoOpen ticker
    MemoSRCEneutralmediumExperimental

    1st Source

    The T+1 earnings follow-up remains unresolved: the packet lacks a Q2 company result, transcript, analyst reaction, verified post-release price attribution, and social sentiment aggregate. The latest primary print was operationally positive but mixed, with rec...

    Memo freshness
    2026-07-17
    Coverage
    Coverage partial
    Base target $81.00Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoSIDUneutralmediumExperimental

    Sidus Space

    The packet contains limited, mostly low-signal recent headline flow and no usable social, options, short-interest, or employee-sentiment data; zero values above indicate unavailable metrics rather than neutral readings. Primary-source evidence is stronger on...

    Memo freshness
    2026-07-17
    Coverage
    Coverage available
    Base target $1.80Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoSTXneutralmediumExperimental

    Seagate

    News tone is negative near term because of a broad chip and storage selloff, while company-specific operating evidence remains anchored to the strong April quarter and prior Q4 guide. The July 16 queue event appears misdated; official company information indi...

    Memo freshness
    2026-07-17
    Coverage
    Coverage partial
    Base target $800.00Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoCBSHhighExperimental

    Commerce Bancshares

    Primary-source earnings tone is constructive, but the post-print market reaction and analyst revision picture are thin in the packet. Social, options, short-interest and employee-sentiment data were unavailable; the zero values indicate missing coverage, not...

    Memo freshness
    2026-07-17
    Coverage
    Coverage available
    Base target $62.00Base-case probability 55%Closest price scenario: Base case
    Open memoOpen ticker
    MemoENLVneutralmediumExperimental

    Enlivex

    The latest company headline is directionally positive because of the RMAT designation, but the evidence base remains thin. The packet provides no social coverage, verified post-release price reaction, analyst revisions, or options/short-interest data; confide...

    Memo freshness
    2026-07-17
    Coverage
    Coverage partial
    Base target $5.00Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoTFCmediumExperimental

    Truist Financial

    The evidence tone is positive after a strong Q2 print, but the packet lacks post-release price action, analyst target changes, and social coverage. The July 16 anchor predates the July 17 filing, so market confirmation remains unavailable; treat this as a ten...

    Memo freshness
    2026-07-17
    Coverage
    Coverage available
    Base target $55.00Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoPXEDhighExperimental

    Phoenix Education Partners

    News tone is mixed-to-negative after the earnings release: operating stability and margin execution were offset by weaker earnings, enrollment concerns, and analyst target cuts. The RankAlpha anchor is $30.46 on 2026-07-16; a clean, source-consistent post-rel...

    Memo freshness
    2026-07-17
    Coverage
    Coverage available
    Base target $29.00Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoSONmediumExperimental

    Sonoco Products

    Sentiment is mainly event-driven into the July 22 earnings release. Recent external coverage highlights weak demand and difficulty passing through war-related costs, while social and analyst-revision coverage are unavailable. Insider purchases are supportive...

    Memo freshness
    2026-07-17
    Coverage
    Coverage available
    Base target $62.00Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoSTThighExperimental

    State Street

    T+1 post-earnings tone is positive: primary company materials confirm a strong beat, improved FY2026 outlook and new medium-term targets, while secondary coverage reported an initial share-price rise of about 2%. Post-print analyst revisions and target change...

    Memo freshness
    2026-07-17
    Coverage
    Coverage partial
    Base target $193.00Base-case probability 55%Closest price scenario: Base case
    Open memoOpen ticker
    MemoBRLSsellmediumExperimental

    Borealis Foods

    Primary filing risk dominates the view. Recent news and social coverage are unavailable, and there is no analyst-revision evidence or post-release market-reaction attribution. The deterministic prior is negative across 5-, 20-, 60-, and 120-day horizons, supp...

    Memo freshness
    2026-07-17
    Coverage
    Coverage available
    Base target $0.70Base-case probability 45%Closest price scenario: Base case
    Open memoOpen ticker
    EventImpact 85
    Dassault Systèmes in talks to buy drug trial software company for about $2bn

    Dassault Systèmes in talks to buy drug trial software company for about $2bn

    Freshness
    2026-07-16 14:20 ET
    Source trail
    External coverage
    www.ft.com
    Open source article
    EventATAIImpact 90
    Eli Lilly to buy psychedelics maker AtaiBeckley for $2.8 billion as experimental treatments gain traction

    Eli Lilly to buy psychedelics maker AtaiBeckley for $2.8 billion as experimental treatments gain traction

    Freshness
    2026-07-16 06:52 ET
    Source trail
    External coverage
    www.cnbc.com
    Open source article
    EventImpact 83
    Chip giant TSMC pledges another $100bn to expand US production

    Chip giant TSMC pledges another $100bn to expand US production

    Freshness
    2026-07-16 06:31 ET
    Source trail
    External coverage
    www.bbc.co.uk
    Open source article
    EventKKRImpact 85
    DCC Gets Sweetened Takeover Bid From KKR, ECP

    DCC Gets Sweetened Takeover Bid From KKR, ECP

    Freshness
    2026-07-16 02:57 ET
    Source trail
    External coverage
    www.bloomberg.com
    Open source article
    EventAAImpact 90company update
    Aluminum giant Alcoa to buy South32s assets in deal valued at $5.6B

    Aluminum giant Alcoa to buy South32s assets in deal valued at $5.6B

    Freshness
    2026-07-16 00:01 ET
    Source trail
    External coverage
    finance.yahoo.com
    Open source article
    EventAAImpact 85m&a
    Alcoa to Acquire Mining, Processing Assets From South32 for $4.1 Billion

    Alcoa to Acquire Mining, Processing Assets From South32 for $4.1 Billion

    Freshness
    2026-07-16 00:01 ET
    Source trail
    External coverage
    www.wsj.com
    Open source article
    MemoMTBmediumExperimental

    M&T Bank

    Primary company evidence and recent earnings coverage are positive, but the immediate market reaction was modest and mixed rather than a decisive rerating. No usable social, options, short-interest, employee, or analyst-revision data is available in the packe...

    Memo freshness
    2026-07-16
    Coverage
    Coverage available
    Base target $255.00Base-case probability 55%Closest price scenario: Base case
    Open memoOpen ticker
    MemoHAYWmediumExperimental

    Hayward

    Recent headlines are constructive because they include raised guidance and a Q2 earnings-date announcement. No verified post-print price reaction, analyst revisions, options data, short-interest data, employee score, or usable social coverage was provided; mi...

    Memo freshness
    2026-07-16
    Coverage
    Coverage available
    Base target $17.25Base-case probability 50%Closest price scenario: Bear case
    Open memoOpen ticker
    MemoMIDDmediumExperimental

    Middleby

    Headline tone is constructive after the Q1 beat-and-raise and July 6 spin-off, but social, options, short-interest, employee-review, and post-print analyst-revision data are unavailable in the packet. This remains a cautious post-spin monitoring thesis rather...

    Memo freshness
    2026-07-16
    Coverage
    Coverage available
    Base target $158.44Base-case probability 50%Closest price scenario: Bear case
    Open memoOpen ticker
    MemoBBWImediumExperimental

    Bath Body Works

    Recent coverage is mixed: Ulta expansion and brand-refresh narratives are constructive, while weak sentiment and a reported Goldman downgrade weigh on the near-term tone. Social, options and short-interest data are unavailable, so conviction remains based pri...

    Memo freshness
    2026-07-16
    Coverage
    Coverage available
    Base target $23.30Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoWYFImediumExperimental

    WhiteFiber

    Primary filing and investor-material support is strong, but forward visibility remains limited by commissioning, funding, and pipeline-conversion risk. Recent stored earnings commentary is secondary MarketBeat context rather than a confirmed official company...

    Memo freshness
    2026-07-16
    Coverage
    Coverage available
    Base target $28.00Base-case probability 50%Closest price scenario: Bear case
    Open memoOpen ticker
    MemoKRMDbuymediumExperimental

    KORU Medical

    Recent news tone is constructive because Q1 growth and full-year guidance were reiterated, but the evidence base is low-coverage and lacks usable social, options, short-interest, employee, analyst-revision, or post-print market-reaction data. The thesis shoul...

    Memo freshness
    2026-07-16
    Coverage
    Coverage available
    Base target $5.25Base-case probability 50%Closest price scenario: Bear case
    Open memoOpen ticker
    MemoWLYmediumExperimental

    John Wiley Sons

    Recent news tone is constructive and concentrated around FY2026 results, margin expansion, AI momentum, cash flow, and shareholder returns. Social, options, short-interest, employee-review, and post-print analyst-revision data are unavailable, so the sentimen...

    Memo freshness
    2026-07-16
    Coverage
    Coverage available
    Base target $60.00Base-case probability 50%Closest price scenario: Bear case
    Open memoOpen ticker
    MemoPLBChighExperimental

    Plumas Bancorp

    Primary-source operating evidence is positive, but coverage is low. The earnings release confirms strong results; consensus surprise, analyst revisions, and post-release price reaction are unavailable. Social context and recent-news coverage were absent, so s...

    Memo freshness
    2026-07-16
    Coverage
    Coverage available
    Base target $65.00Base-case probability 55%Closest price scenario: Base case
    Open memoOpen ticker
    MemoCARSneutralmediumExperimental

    Cars.com

    Primary-source tone is cautiously constructive after Q1 margin, cash-flow, cost-control, and repurchase progress [#SEC-8K-2026-04-09][#SEC-8K-2026-05-07]. News flow is sparse and mostly non-financial; analyst revisions, options, short-interest, and social dat...

    Memo freshness
    2026-07-16
    Coverage
    Coverage available
    Base target $12.50Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoELFmediumExperimental

    e.l.f Beauty

    The primary company source provides a quantified FY2027 outlook and brand-level operating context, improving the evidence base, but the company’s investor-events page shows no confirmed upcoming event. No verified post-print price reaction or analyst target a...

    Memo freshness
    2026-07-16
    Coverage
    Coverage available
    Base target $73.00Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoUNBmediumExperimental

    Union Bankshares

    Low-coverage, filing-led tone is modestly positive after the Q2 earnings release, but the packet does not provide a post-print price reaction, analyst revisions, options data, short interest, employee sentiment, or sufficient social coverage. Missing reaction...

    Memo freshness
    2026-07-16
    Coverage
    Coverage available
    Base target $27.20Base-case probability 55%Closest price scenario: Base case
    Open memoOpen ticker
    MemoGSBCneutralmediumExperimental

    Great Southern Bancorp

    The post-print tone is mixed: the company beat the packet's preliminary EPS and revenue expectations, but reported earnings declined year over year and the beat was partly offset by restructuring costs. The available price snapshot shows GSBC at $77.54, up ab...

    Memo freshness
    2026-07-16
    Coverage
    Coverage available
    Base target $76.00Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoEVOneutralmediumExperimental

    Evotec SE

    News tone is strongly negative after the preliminary H1 update and guidance cut, while the reported post-print market reaction was sharply adverse. Analyst revisions are available but mixed: TD Cowen downgraded to Hold and cut its target to $2, while H.C. Wai...

    Memo freshness
    2026-07-16
    Coverage
    Coverage partial
    Base target $2.15Base-case probability 45%Closest price scenario: Base case
    Open memoOpen ticker
    MemoSKYWmediumExperimental

    SkyWest

    Recent headline flow is mixed, combining a Q2 results-call notice and COO appointment with a Goldman downgrade tied to block-hour growth concerns. Social, options, short-interest, employee-score, and analyst-revision data are unavailable or insufficient in th...

    Memo freshness
    2026-07-16
    Coverage
    Coverage available
    Base target $110.00Base-case probability 50%Closest price scenario: Bear case
    Open memoOpen ticker
    MemoFMAOmediumExperimental

    Farmers Merchants Bancorp

    The packet contains no recent-news or social-sentiment observations, and no analyst revision or market-reaction evidence. The available target median sits slightly below the anchor price. Primary-source evidence is strong for Q1 operations and the dividend, b...

    Memo freshness
    2026-07-16
    Coverage
    Coverage available
    Base target $28.75Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoPNChighExperimental

    PNC Financial Services Group

    The earnings-news tone is positive on the beat and record revenue, but a post-print Zacks headline characterized the stock as down despite the results. The exact price reaction and analyst revision signal are unavailable, and no social context was supplied; t...

    Memo freshness
    2026-07-16
    Coverage
    Coverage available
    Base target $275.00Base-case probability 55%Closest price scenario: Bear case
    Open memoOpen ticker
    MemoELVneutralhighExperimental

    Elevance Health

    Primary-source tone is positive on the Q2 beat and guidance raise, but the operating read-through is mixed because medical-cost trends, membership attrition, and margin compression persist. Recent headlines indicated underperformance versus competitors and co...

    Memo freshness
    2026-07-16
    Coverage
    Coverage partial
    Base target $430.00Base-case probability 50%Closest price scenario: Bear case
    Open memoOpen ticker
    MemoJBHTneutralhighExperimental

    J.B Hunt Transport Services

    News tone is positive after the earnings beat, but follow-through is mixed: recent coverage described a jump while the latest quote was $276.28, down $4.505 or 1.6% from the prior close. Social, options, short-interest, and employee-sentiment data were unavai...

    Memo freshness
    2026-07-16
    Coverage
    Coverage available
    Base target $296.00Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoALKTmediumExperimental

    Alkami

    The operating evidence is stronger than the near-term price setup: Q1 results and guidance were constructive, but the deterministic signal remains negative and the packet contains only one recent news item, no social coverage, and no analyst revision or post-...

    Memo freshness
    2026-07-16
    Coverage
    Coverage available
    Base target $18.75Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoHOMBhighExperimental

    Home BancShares

    The primary earnings release is positive on profitability, revenue, acquisition contribution, and capital returns, but the packet lacks verified post-release price reaction, analyst revisions, options data, and social coverage. This supports a constructive bu...

    Memo freshness
    2026-07-16
    Coverage
    Coverage available
    Base target $31.00Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoCINTmediumExperimental

    CI&T

    News flow is favorable around Q1 growth and AI partnerships, and an official CI&T Claude Partner Network release confirms the strategic positioning [#IR-2026-06-08]. However, the earnings evidence is primarily stored third-party context, social coverage is un...

    Memo freshness
    2026-07-16
    Coverage
    Coverage available
    Base target $4.25Base-case probability 55%Closest price scenario: Bear case
    Open memoOpen ticker
    MemoTVGNneutralmediumExperimental

    Tevogen Bio

    The evidence is primarily filing-based, with no recent news or social coverage and no reliable analyst-reaction data. The peer set is loose, so the report remains a cautious monitoring view rather than a strong directional thesis [#SEC-10Q-2026-05-15].

    Memo freshness
    2026-07-16
    Coverage
    Coverage partial
    Base target $3.30Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoFASTneutralhighExperimental

    Fastenal

    News tone is mixed-to-negative after Q2: operating results were strong, but coverage emphasized that the growth rate was not enough for the stock. No usable social, options, short-interest, employee, or post-print analyst-revision data is present, so convicti...

    Memo freshness
    2026-07-16
    Coverage
    Coverage available
    Base target $48.58Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoEGYneutralmediumExperimental

    VAALCO Energy

    Company operational news was constructive in June, but the stock was $5.30 on the July 15 anchor date, below the prior baseline's May post-earnings level. Analyst revision evidence is limited to one stored secondary earnings commentary, social data is unavail...

    Memo freshness
    2026-07-16
    Coverage
    Coverage available
    Base target $5.75Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoTCMDneutralmediumExperimental

    Tactile

    Recent packet news is mildly positive around Q1 execution and the MyoSleeve update, but coverage remains thin and no dependable analyst-revision, options, short-interest, employee, or social dataset is supplied. Primary evidence supports monitoring rather tha...

    Memo freshness
    2026-07-16
    Coverage
    Coverage available
    Base target $30.00Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoRNACmediumExperimental

    Cartesian Therapeutics

    Primary-source support is strong for financing and clinical-program updates, but coverage is low, recent news flow is sparse, social data are unavailable, analyst-target breadth is undisclosed, and no direct operating peer set was validated. The stock remains...

    Memo freshness
    2026-07-16
    Coverage
    Coverage partial
    Base target $9.50Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoFHNneutralmediumExperimental

    First Horizon

    Constructive but cautious post-earnings tone: the company reported a modest EPS beat and strong returns, while NIM and expense trends were mixed. Social coverage, post-release price reaction, options data, short interest, and analyst revisions are unavailable...

    Memo freshness
    2026-07-16
    Coverage
    Coverage available
    Base target $27.50Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoNXGLneutralmediumExperimental

    NexGel

    Low-coverage, monitoring-style view. The earnings transcript provides a meaningful positive operating hook through the completed acquisition and expected Q2 contribution, but the Q1 decline, limited cash, financing dependence, and lack of analyst or social re...

    Memo freshness
    2026-07-16
    Coverage
    Coverage available
    Base target $0.52Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoCWBCmediumExperimental

    Community West Bancshares

    News tone is modestly positive from the Q1 beat and merger completion, but the scheduled 2026-07-15 follow-up could not be converted into a confirmed Q2 earnings read-through: the checked company quarterly-results page surfaced Q1 2026 as the latest result ([...

    Memo freshness
    2026-07-16
    Coverage
    Coverage available
    Base target $28.88Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoALHCmediumExperimental

    Alignment Healthcare

    News flow is negative because of the whistleblower allegations and related legal solicitation. Social, options, short-interest, and employee-sentiment data are not available in the packet. The upcoming Q2 print is a clear event, but missing analyst revisions...

    Memo freshness
    2026-07-16
    Coverage
    Coverage available
    Base target $20.00Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoBNYhighExperimental

    Bank of New York Mellon

    News tone is positive following the earnings release and reported beat, while the stored pre-release consensus had also been revised upward. However, social coverage, post-print price reaction, options data, short interest, employee sentiment, and post-earnin...

    Memo freshness
    2026-07-16
    Coverage
    Coverage partial
    Base target $164.00Base-case probability 55%Closest price scenario: Base case
    Open memoOpen ticker
    MemoPKBKneutralmediumExperimental

    Parke Bancorp

    Sentiment is cautiously neutral-to-positive. Q1 company-reported fundamentals were strong, but the scheduled July 15 earnings follow-up lacks verified Q2 results and market-reaction evidence. Analyst targets, revisions, options data, short interest, and socia...

    Memo freshness
    2026-07-16
    Coverage
    Coverage available
    Base target $35.00Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoALOYneutralmediumExperimental

    REalloys

    The deterministic packet shifted positive, but the evidence remains a monitoring thesis rather than a confirmed earnings-driven rerating. Recent company communications are strategically constructive, while the last confirmed filing still shows substantial ope...

    Memo freshness
    2026-07-16
    Coverage
    Coverage available
    Base target $11.00Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoJNJneutralmediumExperimental

    Johnson Johnson

    The earnings release is fundamentally positive, but the latest price snapshot shows a roughly 2.7% decline, producing mixed near-term sentiment. News attention is high; social, options, short-interest, employee, and fresh analyst-revision evidence are unavail...

    Memo freshness
    2026-07-16
    Coverage
    Coverage available
    Base target $271.43Base-case probability 55%Closest price scenario: Base case
    Open memoOpen ticker
    MemoSKYQhighExperimental

    Sky Quarry

    Primary filing evidence is strong, but forward visibility is weak. The packet contains no usable social context, analyst targets, options data, short-interest data, or employee sentiment; zero values indicate unavailable measures rather than neutral readings....

    Memo freshness
    2026-07-16
    Coverage
    Coverage available
    Base target $3.00Base-case probability 40%Closest price scenario: Bull case
    Open memoOpen ticker
    MemoXTIAneutralmediumExperimental

    XTI Aerospace

    Cautious-neutral sentiment. SEC-backed company disclosures provide specific targets and liquidity data, while available earnings commentary is secondary and analyst-revision coverage is unavailable. Social, options, short-interest, and employee-sentiment data...

    Memo freshness
    2026-07-16
    Coverage
    Coverage available
    Base target $1.50Base-case probability 45%Closest price scenario: Base case
    Open memoOpen ticker
    MemoUALhighExperimental

    United Airlines

    News tone is mixed: primary company results were strong and guidance increased, while fuel costs and reported after-hours selling offset the headline beat. Analyst revisions and target changes are unavailable, and social coverage is absent, so the positive de...

    Memo freshness
    2026-07-16
    Coverage
    Coverage partial
    Base target $150.00Base-case probability 55%Closest price scenario: Bear case
    Open memoOpen ticker
    MemoSLGNmediumExperimental

    Silgan

    Recent coverage is event-heavy around Q1 results, the dividend, and the scheduled July 29 report. Primary evidence remains constructive on guidance and cash flow but limited on forward execution; social, options, short-interest, employee, and detailed analyst...

    Memo freshness
    2026-07-16
    Coverage
    Coverage available
    Base target $48.50Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoMShighExperimental

    Morgan Stanley

    News tone is positive after the Q2 beat and record segment results, with high headline activity. The post-print reaction was characterized as a gain by trusted coverage, but analyst target changes, estimate revisions, options data, short interest, employee se...

    Memo freshness
    2026-07-16
    Coverage
    Coverage partial
    Base target $232.00Base-case probability 55%Closest price scenario: Base case
    Open memoOpen ticker
    MemoBVFLmediumExperimental

    BV Financial

    The packet contains no recent news or social context. Stored Zacks coverage reported a roughly 2% post-Q1 decline and weaker performance versus the S&P 500, but no analyst target or estimate-revision signal is available. The July earnings trigger remains unco...

    Memo freshness
    2026-07-16
    Coverage
    Coverage available
    Base target $20.00Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoKAROneutralmediumExperimental

    Karooooo

    News tone is positive on the Q1 operating performance and reaffirmed guidance, but the immediate market response was muted or negative as FX headwinds offset the beat. The run remains T+1, with no reliable post-print analyst revision set or usable social data...

    Memo freshness
    2026-07-16
    Coverage
    Coverage available
    Base target $62.73Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoHSTMmediumExperimental

    HealthStream

    News tone is mildly constructive because Q1 results were described as record-setting and FY2026 guidance was reaffirmed, but headline volume is low. No usable social, options, short-interest, employee, or analyst-revision data was provided; missing market-rea...

    Memo freshness
    2026-07-16
    Coverage
    Coverage available
    Base target $32.00Base-case probability 50%Closest price scenario: Bear case
    Open memoOpen ticker
    EventPYPLImpact 85
    PayPal Receives $53 Billion Takeover Offer Involving Stripe

    PayPal Receives $53 Billion Takeover Offer Involving Stripe

    Freshness
    2026-07-15 16:59 ET
    Source trail
    External coverage
    www.nytimes.com
    Open source article
    EventCAGImpact 90
    A big dividend cut and a $2 billion charge: Conagra’s results signal more pain ahead for food industry

    A big dividend cut and a $2 billion charge: Conagra’s results signal more pain ahead for food industry

    Freshness
    2026-07-15 14:09 ET
    Source trail
    External coverage
    www.marketwatch.com
    Open source article
    EventBCMLImpact 90earnings
    BayCom Corp Reports 2026 First Quarter Earnings of $8.2 Million

    BayCom Corp Reports 2026 First Quarter Earnings of $8.2 Million

    Freshness
    2026-07-15 04:07 ET
    Source trail
    External coverage
    www.businesswire.com
    Open source article
    EventCWBCImpact 90earnings
    Community West Bancshares Reports Earnings Results for the Quarter Ended March 31, 2026, and Quarterly Dividend

    Community West Bancshares Reports Earnings Results for the Quarter Ended March 31, 2026, and Quarterly Dividend

    Freshness
    2026-07-15 00:05 ET
    Source trail
    External coverage
    www.businesswire.com
    Open source article
    EventCCTGImpact 90earnings
    CCSC Technology International Holdings Limited Reports Financial Results for Fiscal Year 2024

    CCSC Technology International Holdings Limited Reports Financial Results for Fiscal Year 2024

    Freshness
    2026-07-15 00:05 ET
    Source trail
    External coverage
    www.prnewswire.com
    Open source article
    MemoFCneutralmediumExperimental

    Franklin Covey

    News tone is mixed: the SEC-filed release shows improving EBITDA, invoiced amounts, deferred revenue, and net income, but also a revenue-guidance reduction, margin pressure, and weaker free cash flow [#SEC-8K-2026-07-01]. Social coverage, options data, short...

    Memo freshness
    2026-07-15
    Coverage
    Coverage available
    Base target $24.00Base-case probability 50%Closest price scenario: Bear case
    Open memoOpen ticker
    MemoPLTKmediumExperimental

    Playtika

    Primary-source tone is positive following Q1 revenue growth, raised 2026 guidance, Disney Solitaire momentum, and record DTC performance [#SEC-8K-2026-05-08]. However, news flow is thin, social data and analyst revisions are unavailable, and the post-earnings...

    Memo freshness
    2026-07-15
    Coverage
    Coverage available
    Base target $5.05Base-case probability 50%Closest price scenario: Bear case
    Open memoOpen ticker
    MemoPHMmediumExperimental

    PulteGroup

    News tone is mildly constructive around community launches and recent share performance, but coverage also highlights D.R. Horton over PHM. Social, options, short-interest and employee-sentiment data are unavailable; the July earnings report remains the key e...

    Memo freshness
    2026-07-15
    Coverage
    Coverage available
    Base target $143.00Base-case probability 50%Closest price scenario: Bear case
    Open memoOpen ticker
    MemoHNGEmediumExperimental

    Hinge Health

    News flow is constructive, led by strong Q1 results, raised guidance, Investor Day messaging, and the scheduled August 4 earnings report. Social, options, short-interest, employee-review, and analyst-revision data are unavailable, so confidence remains modera...

    Memo freshness
    2026-07-15
    Coverage
    Coverage available
    Base target $98.00Base-case probability 55%Closest price scenario: Base case
    Open memoOpen ticker
    MemoTUSKmediumExperimental

    Mammoth Energy Services

    Recent company earnings materials are constructive, emphasizing a Q1 inflection, positive adjusted EBITDA, raised 2026 outlook, aviation utilization, and capital returns [#PR-EARNINGS-2026-05-11] [#EARNINGS-TRANSCRIPT-2026Q1] [#SEC-8K-2026-05-11]. However, th...

    Memo freshness
    2026-07-15
    Coverage
    Coverage available
    Base target $3.40Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoNNBRmediumExperimental

    NN

    Primary-source operating evidence remains constructive on new-business awards and end-market repositioning, while the newest verified corporate event is financing-related and dilutive. Recent headline activity is positive but thin and partly secondary/noisy;...

    Memo freshness
    2026-07-15
    Coverage
    Coverage available
    Base target $4.00Base-case probability 50%Closest price scenario: Bear case
    Open memoOpen ticker
    MemoBVSmediumExperimental

    Bioventus

    Primary SEC evidence is constructive after Q1, and the deterministic prior is positive. However, coverage is low, news is sparse, social/options/short-interest data are unavailable, and valuation plus rebate normalization risks support a monitoring-style rath...

    Memo freshness
    2026-07-15
    Coverage
    Coverage available
    Base target $13.50Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoATRAmediumExperimental

    Atara Biotherapeutics

    News flow is concentrated around Q1 results, regulatory path and corporate updates. Social sentiment, options skew, short interest and employee-rating data are unavailable in the packet; no analyst revision or target-change evidence is available. The determin...

    Memo freshness
    2026-07-15
    Coverage
    Coverage available
    Base target $7.50Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoSNALneutralmediumExperimental

    Snail

    Headline flow is mixed: ARK launch activity is constructive, but the July 2 delisting disclosure is the most consequential recent signal. Social, options, short-interest, employee, and analyst-revision data are unavailable, so the sentiment read is primarily...

    Memo freshness
    2026-07-15
    Coverage
    Coverage available
    Base target $4.00Base-case probability 45%Closest price scenario: Base case
    Open memoOpen ticker
    MemoWMSmediumExperimental

    Advanced Drainage

    News tone is moderately constructive based on strong FY26 results and the June Investor Day, but the outlook is mixed because management cautioned on FY27 demand. Social sentiment, options data, short interest, employee ratings, analyst revisions, and post-pr...

    Memo freshness
    2026-07-15
    Coverage
    Coverage available
    Base target $166.00Base-case probability 55%Closest price scenario: Base case
    Open memoOpen ticker
    MemoKTTAneutralmediumExperimental

    Pasithea Therapeutics

    Primary-source company updates are constructive on tolerability, NF1 study expansion, and upcoming Q4 2026 data, but the stock remained near $0.48 as of 2026-07-14. There is no usable social or analyst-revision signal in the packet, so the positive clinical n...

    Memo freshness
    2026-07-15
    Coverage
    Coverage available
    Base target $0.45Base-case probability 55%Closest price scenario: Base case
    Open memoOpen ticker
    MemoOImediumExperimental

    O-I Glass

    News flow is moderate, with the latest stored company announcement focused on scheduling the Q2 earnings release and call [#PR-EARNINGS-2026-07-09]. Social context and analyst-revision data are unavailable. The latest reported quarter was below expectations w...

    Memo freshness
    2026-07-15
    Coverage
    Coverage available
    Base target $9.50Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoMMEDmediumExperimental

    MiniMed Group

    Recent news tone is constructive: coverage highlighted strong earnings and investors looking past a softer outlook. Primary company and SEC materials support the growth, launch, and FY27-guidance claims, but analyst revision data and social coverage are unava...

    Memo freshness
    2026-07-15
    Coverage
    Coverage available
    Base target $15.90Base-case probability 55%Closest price scenario: Base case
    Open memoOpen ticker
    MemoAVAHneutralmediumExperimental

    Aveanna Healthcare

    Headline flow is moderately constructive, centered on strong Q1 results, higher guidance, and the Family First transaction. The market reaction was reported positively, but no quantified post-release move or analyst-revision series is available; social covera...

    Memo freshness
    2026-07-15
    Coverage
    Coverage available
    Base target $10.35Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoXZOneutralmediumExperimental

    Exzeo Group

    Headline tone is modestly positive after Q1 results showing growth in revenue, managed premium, ARR and free cash flow, despite margin investment [#SEC-8K-2026-05-06]. Social, options, short-interest and employee-sentiment data are unavailable in the packet....

    Memo freshness
    2026-07-15
    Coverage
    Coverage available
    Base target $17.50Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoOPRTmediumExperimental

    Oportun Financial

    No recent-news or social aggregate is available, and options, short-interest, and employee data are unavailable. Primary-source evidence is mixed: profitability, liquidity, and funding costs improved, while credit and growth metrics remain pressured.

    Memo freshness
    2026-07-15
    Coverage
    Coverage available
    Base target $6.25Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoANFbuymediumExperimental

    Abercrombie Fitch

    Tone is mixed-positive rather than aggressively bullish. Official Q1 results support maintained guidance, Americas/APAC strength, positive cash flow, and repurchases, but also show negative total comps, lower margin, Hollister stagnation, and EMEA weakness [#...

    Memo freshness
    2026-07-15
    Coverage
    Coverage available
    Base target $106.00Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoDALneutralmediumExperimental

    Delta Air Lines

    News tone is mixed-positive on the earnings beat and explicit September-quarter outlook, but fuel-cost concerns and reported analyst skepticism temper the signal. Social, options, short-interest, and employee-sentiment metrics are unavailable in the packet, a...

    Memo freshness
    2026-07-15
    Coverage
    Coverage partial
    Base target $83.00Base-case probability 1%Closest price scenario: Base case
    Open memoOpen ticker
    MemoSMGmediumExperimental

    Scotts Miracle-Gro

    Tone is moderately positive based on the April results and June guidance reaffirmation, but the July news flow is thin and mainly promotional/personnel-oriented. No current analyst revision or post-print target-change evidence is available, so the thesis rema...

    Memo freshness
    2026-07-15
    Coverage
    Coverage available
    Base target $70.00Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoTREEmediumExperimental

    LendingTree

    News coverage is sparse and mostly unrelated to TREE. The available earnings narrative is positive, but the reported post-earnings selloff makes sentiment mixed; the current price indicates a partial recovery from the level cited in the stored earnings contex...

    Memo freshness
    2026-07-15
    Coverage
    Coverage available
    Base target $52.00Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoBHVNneutralmediumExperimental

    Biohaven

    Company disclosures provide primary-source milestone support, but social data, analyst-count data, options data, and a clean post-news reaction decomposition are unavailable. The peer set is loose, and deterministic signals are negative; this remains a low-co...

    Memo freshness
    2026-07-15
    Coverage
    Coverage available
    Base target $14.00Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoCBKmediumExperimental

    Commercial Bancgroup

    Company-specific news flow, social context, options data, and analyst-revision coverage are unavailable or thin. The deterministic prior is positive, but the low-coverage setup and limited forward data support monitoring rather than a high-conviction thesis.

    Memo freshness
    2026-07-15
    Coverage
    Coverage available
    Base target $34.00Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoACUneutralmediumExperimental

    Acme United

    Tone is mixed: the primary earnings filing confirms strong sales growth and strategic investments, but also confirms weaker Q1 earnings from tariff-related costs and higher expenses [#SEC-8K-2026-04-23]. News coverage is thin, social coverage is unavailable,...

    Memo freshness
    2026-07-15
    Coverage
    Coverage available
    Base target $52.00Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoBBSIneutralmediumExperimental

    Barrett Business Services

    News tone is mixed: operating metrics and adjusted EPS were modestly better than consensus, while the headline GAAP loss and one-time tax charge remain negative framing. Social, options, short-interest, employee-review, and post-release price-reaction data ar...

    Memo freshness
    2026-07-15
    Coverage
    Coverage available
    Base target $41.50Base-case probability 55%Closest price scenario: Base case
    Open memoOpen ticker
    MemoIBMmediumExperimental

    International Business Machines

    News tone has turned sharply negative after IBM disclosed preliminary Q2 weakness, with Reuters reporting that shares sank; the exact post-release price reaction is unavailable. Primary-source evidence remains strong, but the preliminary nature of the figures...

    Memo freshness
    2026-07-15
    Coverage
    Coverage available
    Base target $225.00Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    EventAGENImpact 90earnings
    Agenus Reports First Quarter 2026 Financial Results and Highlights BOT+BAL Execution Across Global Access and Phase 3 Development

    Agenus Reports First Quarter 2026 Financial Results and Highlights BOT+BAL Execution Across Global Access and Phase 3 Development

    Freshness
    2026-07-14 04:02 ET
    Source trail
    External coverage
    www.businesswire.com
    Open source article
    EventANGOImpact 90earnings
    AngioDynamics Reports Fiscal Year 2026 Third Quarter Financial Results; Sustained Double-Digit Med Tech Growth Drives Continued Profitability

    AngioDynamics Reports Fiscal Year 2026 Third Quarter Financial Results; Sustained Double-Digit Med Tech Growth Drives Continued Profitability

    Freshness
    2026-07-14 00:01 ET
    Source trail
    External coverage
    www.businesswire.com
    Open source article
    EventImpact 85
    SocGen Sees $76 Billion of JGB Buying If GPIF Rebalances Assets

    SocGen Sees $76 Billion of JGB Buying If GPIF Rebalances Assets

    Freshness
    2026-07-13 21:32 ET
    Source trail
    External coverage
    www.bloomberg.com
    Open source article
    MemoSINTneutralmediumExperimental

    SINTX

    The packet shows sparse, low-buzz news flow and no usable analyst revision or target-change evidence. Primary-source evidence supports a real product/commercialization strategy and a balance-sheet transaction, but forward visibility remains weak; sentiment is...

    Memo freshness
    2026-07-14
    Coverage
    Coverage available
    Base target $1.50Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoRANIneutralmediumExperimental

    Rani Therapeutics

    Primary-source evidence is strong, but recent news, analyst revisions, options data, short-interest data, employee sentiment and social coverage are unavailable or insufficient. Deterministic scoring remains directionally positive, but the setup is best treat...

    Memo freshness
    2026-07-14
    Coverage
    Coverage available
    Base target $0.75Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoISBAneutralmediumExperimental

    Isabella Bank

    Headline attention is medium because of the Grand River acquisition and ATM filing. Primary disclosures are constructive on Q1 operations but leave forward visibility centered on approvals, integration, funding, and dilution. Social data and usable analyst-re...

    Memo freshness
    2026-07-14
    Coverage
    Coverage available
    Base target $39.50Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoWDFChighExperimental

    WD-40

    At T+3, secondary coverage was clearly positive but remains limited rather than a full consensus dataset: reports cited a Friday gain of more than 23%, a strong earnings beat, and target increases from DA Davidson and Jefferies. Social, options, short-interes...

    Memo freshness
    2026-07-14
    Coverage
    Coverage partial
    Base target $271.67Base-case probability 50%Closest price scenario: Bear case
    Open memoOpen ticker
    MemoRKDAneutralmediumExperimental

    Arcadia Biosciences

    News tone is mixed: company-reported volume and SG&A metrics were constructive, but revenue declined and the net loss was substantial. Coverage is thin and mainly earnings-wire based; analyst reaction, options, short interest, employee sentiment, and social s...

    Memo freshness
    2026-07-14
    Coverage
    Coverage partial
    Base target $0.65Base-case probability 45%Closest price scenario: Base case
    Open memoOpen ticker
    MemoSNXbuymediumExperimental

    TD SYNNEX

    News tone is positive following record fiscal Q2 results, above-outlook performance, Q3 guidance, and capital-return announcements. Social context and analyst-revision detail are unavailable, so the positive tone should be treated as supportive but not decisi...

    Memo freshness
    2026-07-14
    Coverage
    Coverage available
    Base target $270.00Base-case probability 55%Closest price scenario: Base case
    Open memoOpen ticker
    MemoFNDmediumExperimental

    Floor Decor

    News tone is mixed: recent items include a Q2 earnings-call announcement, a new-store opening, and favorable technical commentary. Stored secondary earnings context reports the stock up 13.6% since the Q1 report, but analyst revisions, options data, short int...

    Memo freshness
    2026-07-14
    Coverage
    Coverage available
    Base target $56.00Base-case probability 55%Closest price scenario: Base case
    Open memoOpen ticker
    MemoXOSneutralmediumExperimental

    Xos

    Recent coverage is sparse and headline-driven, with sharp June price swings but no sufficient social or analyst-revision evidence. Primary disclosures confirm real Q1 operating improvement, while capital-structure risk and weak forward visibility support a ca...

    Memo freshness
    2026-07-14
    Coverage
    Coverage available
    Base target $2.20Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoMNTNmediumExperimental

    MNTN

    Recent news flow is moderately positive, led by strong Q1 results and a product integration announcement, but coverage is sparse and mostly company-related. Social, options, short-interest, employee, and analyst-revision data are unavailable; the stock theref...

    Memo freshness
    2026-07-14
    Coverage
    Coverage available
    Base target $11.80Base-case probability 50%Closest price scenario: Bear case
    Open memoOpen ticker
    MemoSMPLmediumExperimental

    Simply Good Foods

    Headline tone is positive because of the Q3 EPS and revenue beat, and packet headlines reported shares rising after results. However, the available anchor does not establish whether the initial reaction held, while no robust post-print analyst-revision datase...

    Memo freshness
    2026-07-14
    Coverage
    Coverage partial
    Base target $14.75Base-case probability 50%Closest price scenario: Bear case
    Open memoOpen ticker
    MemoFBYDmediumExperimental

    Falcon's Beyond Global

    Headline flow is mildly positive because of Q1 results, the VAI agreements, and preferred-stock listing coverage, but the evidence is mainly company-driven. Social coverage is unavailable, and zero-valued sentiment fields indicate missing data rather than neu...

    Memo freshness
    2026-07-14
    Coverage
    Coverage available
    Base target $13.80Base-case probability 50%Closest price scenario: Bear case
    Open memoOpen ticker
    MemoKYNBneutralmediumExperimental

    Kyntra Bio

    Recent company and SEC-reported earnings materials are modestly constructive on pipeline progress, but post-release price reaction, analyst revisions, options data, short interest, employee sentiment, and social coverage are unavailable. The deterministic pri...

    Memo freshness
    2026-07-14
    Coverage
    Coverage available
    Base target $7.13Base-case probability 45%Closest price scenario: Base case
    Open memoOpen ticker
    MemoSLPmediumExperimental

    Simulations Plus

    The official Q3 release was operationally mixed but strategically supported by the announced acquisition. Secondary coverage reported only a modest post-print price response, while post-earnings analyst revision evidence remains limited. With the stock near t...

    Memo freshness
    2026-07-14
    Coverage
    Coverage available
    Base target $18.30Base-case probability 15%Closest price scenario: Base case
    Open memoOpen ticker
    MemoPDSBneutralmediumExperimental

    PDS Biotechnology

    Coverage is low and mostly recap-oriented. News tone is mildly positive around the protocol redesign, but financing sensitivity and the absence of verified analyst revisions keep the setup in monitoring territory. No usable social, options, short-interest, or...

    Memo freshness
    2026-07-14
    Coverage
    Coverage available
    Base target $0.85Base-case probability 45%Closest price scenario: Base case
    Open memoOpen ticker
    MemoIBIOmediumExperimental

    iBio

    The packet contained no recent-news or social coverage, and analyst revision data are unavailable. The July 1 SEC filing provides a meaningful primary-source improvement through a dated EASD presentation and positive NHP pharmacodynamic/body-composition findi...

    Memo freshness
    2026-07-14
    Coverage
    Coverage available
    Base target $1.55Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoJILLmediumExperimental

    J.Jill

    Recent coverage is mixed: the company reported a modest earnings beat and maintained outlook, but the stock reportedly fell 7.6% after the print. Social, options, short-interest, employee-review, and analyst-revision data are unavailable or insufficient, so s...

    Memo freshness
    2026-07-14
    Coverage
    Coverage available
    Base target $17.00Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoAKTSneutralmediumExperimental

    Aktis Oncology

    Sentiment is mixed-to-cautious: company disclosures show meaningful clinical progress, while earnings coverage highlighted an EPS miss. Social context, insider activity, and post-print analyst revisions are unavailable, so there is no independent confirmation...

    Memo freshness
    2026-07-14
    Coverage
    Coverage available
    Base target $29.00Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoSUNCmediumExperimental

    SunocoCorp

    News flow is moderately event-aware because the Q2 reporting date is scheduled, but there is no usable social signal, analyst revision data, options skew, or short-interest data in the packet. The evidence supports a cautious positive monitoring stance rather...

    Memo freshness
    2026-07-14
    Coverage
    Coverage available
    Base target $76.00Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoSKWDhighExperimental

    Skyward Specialty Insurance Group

    News tone is positive because of the strong Q1 operating print, but the principal earnings catalyst is dated and secondary coverage indicated a substantial post-release share-price gain. Social, options, short-interest, employee, and analyst-revision data are...

    Memo freshness
    2026-07-14
    Coverage
    Coverage available
    Base target $64.33Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoBIAFneutralmediumExperimental

    bioAffinity

    Recent company-generated news is active and mixed-to-constructive: Q2 CyPath Lung sales momentum and validation initiatives are positive, while financing remains the dominant risk. Analyst targets, revisions, options data, social coverage, and employee sentim...

    Memo freshness
    2026-07-14
    Coverage
    Coverage available
    Base target $0.80Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoRBLXmediumExperimental

    Roblox

    The news packet is sparse and mixed: the clearest company-specific item is the dated Q2 earnings announcement, while other headlines are broader or speculative. No social or options evidence is available. Primary-source operating evidence is strong, but forwa...

    Memo freshness
    2026-07-14
    Coverage
    Coverage partial
    Base target $62.00Base-case probability 50%Closest price scenario: Bear case
    Open memoOpen ticker
    MemoMUneutralmediumExperimental

    Micron

    News buzz is high and centered on AI-memory strength, but recent coverage is mixed across memory peers. Social, options, short-interest, employee-sentiment, and aggregate news-sentiment data are unavailable; missing analyst revisions should not be treated as...

    Memo freshness
    2026-07-14
    Coverage
    Coverage available
    Base target $1000.00Base-case probability 50%Closest price scenario: Bear case
    Open memoOpen ticker
    EventImpact 83
    Meta expands Louisiana data center in $50B AI push, boosting rural community

    Meta expands Louisiana data center in $50B AI push, boosting rural community

    Freshness
    2026-07-13 11:25 ET
    Source trail
    External coverage
    foxbusiness.com
    Open source article
    EventFBKImpact 90earnings
    FB Financial Corporation Announces 2026 Second Quarter Earnings Call

    FB Financial Corporation Announces 2026 Second Quarter Earnings Call

    Freshness
    2026-07-13 00:14 ET
    Source trail
    External coverage
    www.businesswire.com
    Open source article
    MemoCLLSneutralmediumExperimental

    Cellectis

    Primary company news flow improved in June 2026 after the RMAT designation and EHA clinical update, and the packet includes a secondary market article tying a more than 24% after-hours rally on June 9 to that news. Still, analyst revision evidence is unavaila...

    Memo freshness
    2026-07-13
    Coverage
    Coverage available
    Base target $3.40Base-case probability 46%Closest price scenario: Base case
    Open memoOpen ticker
    MemoHPEhighExperimental

    Hewlett Packard Enterprise

    Primary-source evidence is strong and directionally positive because the June 1, 2026 company filing/release showed a beat-and-raise quarter with record revenue and better cash generation [#SEC-8K-2026-06-01]. Even so, this remains a monitoring-style positive...

    Memo freshness
    2026-07-13
    Coverage
    Coverage available
    Base target $57.00Base-case probability 45%Closest price scenario: Bear case
    Open memoOpen ticker
    MemoDLTRmediumExperimental

    Dollar Tree

    Primary-source tone is constructive: the May 28 earnings release supported a higher FY2026 EPS outlook and the July 2 filing added a sizeable buyback authorization [#SEC-8K-2026-05-28] [#8-K-2026-07-02]. Recent news tone improved further with dual analyst upg...

    Memo freshness
    2026-07-13
    Coverage
    Coverage available
    Base target $128.00Base-case probability 45%Closest price scenario: Base case
    Open memoOpen ticker
    MemoAZZneutralmediumExperimental

    AZZ

    Company-source earnings tone on July 8-9, 2026 was clearly positive, and secondary post-print coverage framed the report as better than expected with a favorable initial market reaction. Still, this T+3 packet does not contain a verified full set of analyst t...

    Memo freshness
    2026-07-13
    Coverage
    Coverage available
    Base target $154.00Base-case probability 1%Closest price scenario: Base case
    Open memoOpen ticker
    MemoASHneutralmediumExperimental

    Ashland

    Deterministic signals remain near-neutral, with low expected returns and only moderate thesis-change intensity, so this stays a monitoring-style Hold rather than a directional call. Primary evidence quality is strong because the April 28, 2026 earnings 8-K pr...

    Memo freshness
    2026-07-13
    Coverage
    Coverage available
    Base target $70.00Base-case probability 50%Closest price scenario: Base case
    Open memoOpen ticker
    MemoMPAAmediumExperimental

    Motorcar Parts of America

    News tone over the last 30 days is moderately positive because coverage centered on better year-end results and the June 30, 2026 acquisition announcement, both supported by company sources. Still, this remains a thin-coverage name: reliable analyst-revision...

    Memo freshness
    2026-07-13
    Coverage
    Coverage available
    Base target $17.00Base-case probability 45%Closest price scenario: Bear case
    Open memoOpen ticker
    MemoBXCneutralmediumExperimental

    BlueLinx

    Headline flow into July 13, 2026 is still concentrated around the May 5-6 earnings release and the late-April product rollout, so buzz exists but is not broad. Primary-source evidence on the quarter is solid, yet there is limited fresh post-earnings confirmat...

    Memo freshness
    2026-07-13
    Coverage
    Coverage available
    Base target $57.00Base-case probability 45%Closest price scenario: Base case
    Open memoOpen ticker
    MemoHELEneutralmediumExperimental

    Helen of Troy

    As of July 10, 2026, the anchor price was $26.34 versus the prior baseline anchor of $28.14 on July 2, 2026, so the post-earnings tape did not show a clean endorsement even after the Q1 beat and higher sales outlook. News tone around July 8-9 was generally co...

    Memo freshness
    2026-07-13
    Coverage
    Coverage available
    Base target $29.00Base-case probability 0%Closest price scenario: Base case
    Open memoOpen ticker
    MemoBEEPneutralmediumExperimental

    Mobile Infrastructure

    Primary-source support is solid, but the stock still reads as a cautious monitoring setup rather than a clean re-rating. Recent information flow is dominated by the May earnings release and the June credit amendment, analyst-revision data is not available in...

    Memo freshness
    2026-07-13
    Coverage
    Coverage available
    Base target $2.15Base-case probability 45%Closest price scenario: Base case
    Open memoOpen ticker
    MemoARTWneutralmediumExperimental

    Art's-Way Manufacturing

    The T+3 earnings follow-up reads as modestly positive but still cautious. The company source confirmed stronger revenue and operating-income trends on July 9-10, 2026, and the first post-release anchor close of $2.505 on July 10, 2026 suggests the market did...

    Memo freshness
    2026-07-13
    Coverage
    Coverage available
    Base target $2.65Base-case probability 45%Closest price scenario: Bear case
    Open memoOpen ticker
    EventFBKImpact 92capital return
    FB Financial Corporation Announces $175 Million Common Stock Repurchase Authorization

    FB Financial Corporation Announces $175 Million Common Stock Repurchase Authorization

    Freshness
    2026-07-12 00:02 ET
    Source trail
    External coverage
    www.businesswire.com
    Open source article
    EventFASTImpact 90earnings
    Fastenal Company Reports 2026 First Quarter Earnings

    Fastenal Company Reports 2026 First Quarter Earnings

    Freshness
    2026-07-12 00:02 ET
    Source trail
    External coverage
    www.businesswire.com
    Open source article
    EventFBKImpact 90earnings
    FB Financial Corporation Announces 2026 Second Quarter Earnings Call

    FB Financial Corporation Announces 2026 Second Quarter Earnings Call

    Freshness
    2026-07-12 00:02 ET
    Source trail
    External coverage
    www.businesswire.com
    Open source article
    EventFBKImpact 90earnings
    FB Financial Corporation Reports First Quarter 2026 Financial Results

    FB Financial Corporation Reports First Quarter 2026 Financial Results

    Freshness
    2026-07-12 00:02 ET
    Source trail
    External coverage
    www.businesswire.com
    Open source article
    EventRAYImpact 90earnings
    Raytech Holding Reports Financial Results for Fiscal Year Ended March 31, 2024

    Raytech Holding Reports Financial Results for Fiscal Year Ended March 31, 2024

    Freshness
    2026-07-12 00:02 ET
    Source trail
    External coverage
    www.globenewswire.com
    Open source article
    EventRAYImpact 90earnings
    Raytech Holding Reports Financial Results for Six Months Ended September 30, 2024

    Raytech Holding Reports Financial Results for Six Months Ended September 30, 2024

    Freshness
    2026-07-12 00:02 ET
    Source trail
    External coverage
    www.globenewswire.com
    Open source article
    Systemic alerts

    Pinned events still in play

    Active macro and cross-asset shocks remain docked here while they are still changing the tape.

    11
    SystemicconflictScore 79
    Joe Lawler on inflation volatility from the resumption of the war in Iran
    2026-07-18 11:07 ETPinned until 2026-07-19 11:07 ET
    SystemicconflictScore 74
    7 killed and more than 50 wounded in Ukrainian drone attack on Russian regions
    2026-07-18 11:07 ETPinned until 2026-07-19 11:07 ET
    SystemicconflictScore 74
    Congress must exercise its power to stop Iran war
    2026-07-18 11:07 ETPinned until 2026-07-19 11:07 ET
    SystemicconflictScore 74
    Canadian tourist injured in bear attack in northeastern Japan
    2026-07-18 08:35 ETPinned until 2026-07-19 08:35 ET
    How to use this page

    Each card carries its own timestamp because events, memos, and macro notes do not all update on the same schedule.

    Memo coverage can be partial. It is best used as a shortcut into deeper research, not as a substitute for primary sources or stock detail.

    If something stands out, open the full memo, jump into ticker detail, or move back to Rankings and Compare for side-by-side review.

    Memo methodologyPipeline and freshness
    Discover tools

    When a catalyst looks important, continue into Screener, Rankings, or Compare to see how the name stacks up against the rest of the field.

    Open ScreenerOpen RankingsOpen Compare
    Coverage snapshot
    Events in view
    29
    Memos in view
    149
    Macro notes in view
    0
    Pinned systemic
    11